Non invasive early cervical cancer screening and detection
This device will be an easy to use, at home, HPV marker detection test.
Project Overview
Cervical cancer is one of the most common cancers in women and also is one of the most treatable cancers when diagnosed early. Current cervical cancer screenings include Pap smears and HPV (human papillomavirus) tests. Testing methods such as the Pap smear must be collected by a medical professional, as it requires cells to be collected from the surface of the cervix and vagina. While these tests are somewhat successful at detecting cervical cancer, they are not easily accessible for people in developing countries and can be an uncomfortable experience. The development of a discrete self-collected urine sample test would increase early cervical cancer detection by providing a cost-effect and culturally sensitive screening option. This device would allow cervical cancer screenings to be easily accessible worldwide, which in turn would prevent many cervical cancer-related deaths.
Team Picture
Files
- Final Notebook (December 15, 2021)
- Final Report (December 15, 2021)
- Final Poster Presentation (December 7, 2021)
- Preliminary Report (October 20, 2021)
- Preliminary Presentation (October 15, 2021)
- PDS (September 24, 2021)
Contact Information
Team Members
- Georgia Hancock - Team Leader
- Mira Baichoo - Communicator
- Josephine Hall - BSAC
- Adrienne Simpson - Co-BWIG
- Cora Williams - Co-BWIG
- Karina Buttram - BPAG
Advisor and Client
- Dr. Tongcheng Qian - Advisor
- Ms. Kebron Zegeye - Client